Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare, benign, inflammatory breast disease occurring in premenopausal women shortly after a recent pregnancy. The origin is unknown but it is commonly mistaken for malignancy and sometimes associated with breast feeding and the use of oral contraceptives.
Biomarker and diagnostic research for granulomatous mastitis has been reported in the published literature.
Estimated prevalence: 1-9 in 100,000 (Uncommon).
10 clinical trials registered, 2 recruiting. Interventions under study include drug therapy, other interventions, and procedural interventions. Pipeline includes 1 PHASE4, 1 PHASE2, 3 PHASE1. Research is primarily sponsored by academic and government institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT06712524](https://clinicaltrials.gov/study/NCT06712524) |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 6:21 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Effect of Different Surgical Approaches of Granulomatous Mastitis |
NA |
Hubei Cancer Hospital |
RECRUITING |
[NCT07422870](https://clinicaltrials.gov/study/NCT07422870) | GRAnulomatous MAstitis REGistry Study | — | European Breast Cancer Research Association of Surgical Trialists | RECRUITING |
221 publications have been identified in PubMed for granulomatous mastitis. Research spans Case Report / Case Series (26%), Review / Meta-Analysis (21%), and Epidemiology / Natural History (15%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 53 | 26% |
Research summaries | 43 | 21% |
Disease patterns and progression | 32 | 15% |
Clinical study results | 24 | 12% |
Testing and diagnosis research | 22 | 11% |
Laboratory research | 22 | 11% |
New treatment approaches | 7 | 3% |
Other research | 4 | 2% |
Yang CW (2026). [PMID: 41427540](https://pubmed.ncbi.nlm.nih.gov/41427540/). *Int J Surg*. [Gene Therapy / Novel Therapeutics]
Rattin J (2026). [PMID: 41808736](https://pubmed.ncbi.nlm.nih.gov/41808736/). *J Clin Tuberc Other Mycobact Dis*. [Case Report / Case Series]
Ahari D (2026). [PMID: 42224904](https://pubmed.ncbi.nlm.nih.gov/42224904/). *Breast*. [Review / Meta-Analysis]
Yazkan C (2026). [PMID: 40791071](https://pubmed.ncbi.nlm.nih.gov/40791071/). *Int J Surg Pathol*. [Case Report / Case Series]
Gautam P (2026). [PMID: 41186119](https://pubmed.ncbi.nlm.nih.gov/41186119/). *Diagn Cytopathol*. [Case Report / Case Series]
Yu M (2026). [PMID: 40865941](https://pubmed.ncbi.nlm.nih.gov/40865941/). *J Biophotonics*. [Diagnostic / Biomarker]
AkbariRad M (2026). [PMID: 41871228](https://pubmed.ncbi.nlm.nih.gov/41871228/). *Breast J*. [Epidemiology / Natural History]
Soran A (2026). [PMID: 41874127](https://pubmed.ncbi.nlm.nih.gov/41874127/). *Eur J Breast Health*. [Epidemiology / Natural History]
Bouhani M (2026). [PMID: 41904549](https://pubmed.ncbi.nlm.nih.gov/41904549/). *J Med Case Rep*. [Case Report / Case Series]
Hashemi Moghanjoughi P (2026). [PMID: 41873817](https://pubmed.ncbi.nlm.nih.gov/41873817/). *Eur J Breast Health*. [Review / Meta-Analysis]
AI-curated news mentioning granulomatous mastitis
Updated Sep 7, 2026
A retrospective case series on idiopathic granulomatous mastitis in the UAE highlights clinical features, management strategies, and patient outcomes. This study contributes to the understanding of this rare condition, which may inform future research and treatment approaches.
A recent study explores the relationship between lesion diameter, inflammatory biomarkers, and clinical severity in idiopathic granulomatous mastitis to inform treatment selection. This research may enhance understanding of the disease and improve patient management strategies.
A narrative review discusses the use of microwave ablation as a treatment for granulomatous lobular mastitis. This technique may offer a minimally invasive option for managing this rare condition.